Form EFFECT CATALYST PHARMACEUTICALS
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 16, 2026 |
| Accession Number: | 0001193125-26-305098 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alibaba's Amap Unveils Full-Stack ABot Upgrade for Embodied AI Robots
- Five Star Bancorp Announces Pricing of Common Stock Offering
- BC Token Hits $0.02, Setting a New All-Time High
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
